Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
Add more filters










Publication year range
1.
Appl Radiat Isot ; 88: 94-8, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24360862

ABSTRACT

BNCT was proposed for the treatment of diffuse, non-resectable tumors in the lung. We performed boron biodistribution studies with 5 administration protocols employing the boron carriers BPA and/or GB-10 in an experimental model of disseminated lung metastases in rats. All 5 protocols were non-toxic and showed preferential tumor boron uptake versus lung. Absolute tumor boron concentration values were therapeutically useful (25-76ppm) for 3 protocols. Dosimetric calculations indicate that BNCT at RA-3 would be potentially therapeutic without exceeding radiotolerance in the lung.


Subject(s)
Boron Compounds/administration & dosage , Boron Compounds/pharmacokinetics , Boron Neutron Capture Therapy/methods , Lung Neoplasms/metabolism , Lung Neoplasms/secondary , Phenylalanine/analogs & derivatives , Animals , Cell Line, Tumor , Drug Combinations , Lung Neoplasms/radiotherapy , Metabolic Clearance Rate , Organ Specificity , Phenylalanine/administration & dosage , Phenylalanine/pharmacokinetics , Radiotherapy Dosage , Rats , Tissue Distribution
2.
Int J Biomed Sci ; 3(4): 258-62, 2007 Dec.
Article in English | MEDLINE | ID: mdl-23675051

ABSTRACT

Photodynamic therapy (PDT) of cancer is based on the cytotoxicity induced by a photosensitizer in the presence of oxygen and visible light, resulting in cell death and tumor regression. This work describes the response of the murine LM3 tumor to PDT using meso-tetra (4-N,N,N-trimethylanilinium) porphine (TMAP). BALB/c mice with intradermal LM3 tumors were subjected to intravenous injection of TMAP (4 mg/kg) followed 24 h later by blue-red light irradiation (λmax: 419, 457, 650 nm) for 60 min (total dose: 290 J/cm(2)) on depilated and glycerol-covered skin over the tumor of anesthetized animals. Control (drug alone, light alone) and PDT treatments (drug + light) were performed once and repeated 48 h later. No significant differences were found between untreated tumors and tumors only treated with TMAP or light. PDT-treated tumors showed almost total but transitory tumor regression (from 3 mm to less than 1 mm) in 8/9 animals, whereas no regression was found in 1/9. PDT response was heterogeneous and each tumor showed different regression and growth delay. The survival of PDT-treated animals was significantly higher than that of TMAP and light controls, showing a lower number of lung metastasis but increased tumor-draining lymph node metastasis. Repeated treatment and reduction of tissue light scattering by glycerol could be useful approaches in studies on PDT of cancer.

3.
Nucl Med Commun ; 22(5): 499-504, 2001 May.
Article in English | MEDLINE | ID: mdl-11388570

ABSTRACT

This work was designed to compare sentinel lymph node (SLN) uptake of 99mTc-labelled human serum albumin colloid (99mTc-HSAC), 99mTc-labelled antimony sulphur colloid (99mTc-SC) and a 99mTc-labelled dextran 70 solution (99mTc-Dx) and their selectivity in the identification of this node in the right rear footpad (RRF) of normal mice and tumour bearing mice. Radiopharmaceutical uptake in the SLN (popliteal lymph node) and the lumbar lymph node (LLN), the second lymphatic node station from RRF, were measured at different time points post-intradermal or intratumoural injection into the RRF of NIH normal mice and of Balb/c mice harbouring the murine mammary tumour M2. 99mTc-HSAC uptake in the SLN was significantly higher than LLN uptake. The 99mTc-SC demonstrated high uptake in SLN, but accumulation in LLN was also high. 99mTc-Dx showed low uptakes in both SLN and LLN. The intradermal injection resulted in a more effective radiopharmaceutical accumulation in SLN than did the intratumoural inoculation. Data also show that increments in tumour volume reduced radiopharmaceutical uptake in the SLN. Our results show that 99mTc-HSAC exhibits the highest uptake in the SLN combined with the smallest amounts of radiopharmaceutical passing through to the LLN. Therefore, 99mTc-HSAC appears to be the best radiopharmaceutical for sentinel node detection.


Subject(s)
Adenocarcinoma/diagnostic imaging , Antimony , Dextrans , Lymph Nodes/diagnostic imaging , Lymphatic Metastasis/diagnostic imaging , Mammary Neoplasms, Experimental/diagnostic imaging , Organotechnetium Compounds , Radiopharmaceuticals , Serum Albumin , Technetium Compounds , Adenocarcinoma/pathology , Animals , Antimony/pharmacokinetics , Dextrans/pharmacokinetics , Female , Humans , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred Strains , Organotechnetium Compounds/pharmacokinetics , Radionuclide Imaging , Radiopharmaceuticals/pharmacokinetics , Reproducibility of Results , Sentinel Lymph Node Biopsy , Serum Albumin/pharmacokinetics , Technetium Compounds/pharmacokinetics , Tissue Distribution
4.
Immunopharmacol Immunotoxicol ; 23(4): 597-606, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11792018

ABSTRACT

Oncomouse is a transgenic mouse carrying an activated v-Ha-ras oncogene under the control of the mouse mammary tumor virus promoter. The objective of this paper was to learn if the in vitro secretion of IL-2 and IFN-gamma and the release of sIL-2R by Oncomice splenocytes and thymocytes depended on the presence of the oncogene product, on the in vivo pretreatment with alcohol, or on the in vitro treatment with cocaine or morphine. Oncomice thymocytes released less sIL-2R than FVB thymocytes. Alcohol did not increase sIL-2R release in Oncomice as it did in FVB mice thymocytes. Oncomice thymocytes secreted more IFN-gamma than FVB thymocytes, their secretion was downregulated by in vivo treatment with alcohol, while it was upregulated in FVB thymocytes. IFN-gamma secretion was lower in Oncomice splenocytes from animals receiving alcohol. Oncomice thymocytes and splenocytes responded in a nearly opposite fashion to their FVB counterparts. Therefore, the in vivo treatment with alcohol modified the in vitro response to cocaine or morphine in an oncogene-dependent and -independent manner. Hence, our results further emphasize the role of v-Ha-ras oncogene in defining the host immune response, and of alcohol in modulating such response.


Subject(s)
Ethanol/toxicity , Genes, ras , Lymphocyte Activation/drug effects , Lymphocytes/drug effects , Animals , Cocaine/toxicity , Enzyme-Linked Immunosorbent Assay , Female , In Vitro Techniques , Interferon-gamma/biosynthesis , Interferon-gamma/drug effects , Interleukin-2/biosynthesis , Lymphocyte Activation/genetics , Lymphocytes/metabolism , Mice , Mice, Inbred Strains , Mice, Transgenic , Morphine/toxicity , Spleen/drug effects , Spleen/metabolism , Spleen/pathology , Thymus Gland/drug effects , Thymus Gland/metabolism , Thymus Gland/pathology
5.
Immunopharmacol Immunotoxicol ; 23(4): 607-16, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11792019

ABSTRACT

Oncomouse is a transgenic mouse carrying an activated v-Ha-ras oncogene under the control of the mouse mammary tumor virus promoter. The objective of this paper was to learn if the in vitro secretion of IL-2 and IFN-gamma and the release of sIL-2R by Oncomice spleen and thymus cells depended on the presence of the oncogene product, on the in vivo pretreatment with cocaine, or on the in vitro treatment with cocaine or morphine. Oncomice thymocytes from different experimental groups released less sIL-2R than FVB thymocytes. Oncomice thymocytes secreted more IFN-gamma than FVB thymocytes. Oncomice thymocytes cultured in the presence of Con A and cocaine showed a diminished release of sIL-2R and a lower secretion of IFN-gamma, a phenomenon not observed in FVB thymocytes. IFN-gamma secretion was lower in Oncomice splenocytes. In general, Oncomice thymocytes and splenocytes responded in a nearly opposite fashion to their FVB counterparts. In this study, the in vitro response to mitogens, cocaine or morphine depended on genetic background and not on the in vivo pretreatment with cocaine. Our results emphasize the role of the v-Ha-ras oncogene in defining the host immune response.


Subject(s)
Cocaine/toxicity , Genes, ras , Lymphocyte Activation/drug effects , Lymphocytes/drug effects , Animals , Enzyme-Linked Immunosorbent Assay , Female , In Vitro Techniques , Injections, Intraperitoneal , Interferon-gamma/biosynthesis , Interferon-gamma/drug effects , Interleukin-2/biosynthesis , Lymphocyte Activation/genetics , Lymphocytes/metabolism , Mice , Mice, Inbred Strains , Mice, Transgenic , Morphine/toxicity , Spleen/drug effects , Spleen/metabolism , Spleen/pathology , Thymus Gland/drug effects , Thymus Gland/metabolism , Thymus Gland/pathology
6.
Oncol Rep ; 7(6): 1363-6, 2000.
Article in English | MEDLINE | ID: mdl-11032945

ABSTRACT

We show here, for the first time, in two very different murine tumors, a mammary one (ectoderm) and a lung one (endoderm), that: tumors have day/night differences of spontaneous apoptosis additional to the well-known circadian rhythm of mitosis. The times of maximal and minimal mitosis and apoptosis changed for a tumor cell line when growing in different organs (as metastasis) or anatomical sites. Both tumor lines, have identical circadian curves when growing in a specific organ or anatomical site. The peaks of apoptosis match with the valleys of mitosis and vice versa.


Subject(s)
Adenocarcinoma/pathology , Apoptosis/physiology , Circadian Rhythm/physiology , Lung Neoplasms/pathology , Mammary Neoplasms, Experimental/pathology , Mitosis/physiology , Tumor Cells, Cultured/pathology , Animals , Cell Division/physiology , Female , Male , Mice , Mice, Inbred BALB C , Neoplasm Transplantation , Peritoneal Cavity/pathology , Spleen/pathology
7.
Immunopharmacol Immunotoxicol ; 22(2): 339-56, 2000 May.
Article in English | MEDLINE | ID: mdl-10952035

ABSTRACT

Transgenic mice (Oncomice) with an activated v-Ha-ras oncogene under the control of the mouse mammary tumor virus promoter develop mammary tumors. We wondered if the expression of the v-Ha-ras oncogene product would induce changes in mice behavioral activity, that could be associated with alterations in their immune system. Behavior was evaluated in an open field study considering line crossings and rears. Oncomice consistently showed less activity than FVB mice. Lieber-DeCarli diet decreased both types of activity in both strains. Cocaine treatment increased line crossings in both strains. Oncomice spleen and thymus cell supernatants contained higher levels of IL-2. Oncomice serum had higher levels of IL-1alpha. Our results suggest a direct association between higher levels of IL-1alpha and lower open field activity. Therefore, we can infer that the increased level of IL-1alpha found in Oncomice, could have a key role in oncogene induced immune and behavioral changes, and could be a requirement to facilitate its transforming activity.


Subject(s)
Behavior, Animal , Genes, ras , Immunity/genetics , Animals , Behavior, Animal/drug effects , Cocaine/toxicity , Ethanol/toxicity , Female , Interleukin-1/metabolism , Interleukin-2/metabolism , Male , Mice , Mice, Transgenic , Neuroimmunomodulation , Species Specificity , ras Proteins/immunology
8.
Immunopharmacol Immunotoxicol ; 21(4): 755-69, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10584210

ABSTRACT

It has been shown that either cocaine or aging alone can alter the immune system. Our objective was to study if the immune system of aging mice was more susceptible to the effect of cocaine than the immune system of young mice. We used a short term (20 days) cocaine daily administration protocol. Cocaine only decreased the absolute number of Thy 1+, CD4+, CD8+, IL-2R+, Mac 1+ and B cells, in the spleen of old mice. Old untreated mice had a lower number of Thy 1+ cells in the thymus, and a higher number of cells expressing IL-2R. Cocaine decreased the number of Thy 1+ cells in the thymus of both age groups. Old mice showed a lower number of IgA+ plasma cells in the intestinal lamina propria (ILP) than young mice. Short term cocaine administration provoked a decrease in the number of CD4+ cells in young mice ILP and of CD8+ cells in old mice ILP. Our data suggest that cocaine can potentiate the effect of aging on the thymus and on the mucosal immune system. Taken together, our findings indicate that aging and cocaine can potentiate each other to impairing the host immune system.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Aging/drug effects , Aging/immunology , Cocaine/administration & dosage , Immune System/drug effects , Animals , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , Body Weight/drug effects , Cell-Free System/immunology , Dose-Response Relationship, Immunologic , Drug Administration Schedule , Female , Immune System/immunology , Injections, Intraperitoneal , Intestinal Mucosa/cytology , Intestinal Mucosa/drug effects , Intestinal Mucosa/immunology , Lymphocyte Count/drug effects , Lymphocyte Subsets/drug effects , Mice , Mice, Inbred C57BL , Organ Size/drug effects , Receptors, Interleukin-2/biosynthesis , Receptors, Interleukin-2/blood , Spleen/anatomy & histology , Spleen/cytology , Spleen/drug effects , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Thy-1 Antigens/biosynthesis , Thymus Gland/anatomy & histology , Thymus Gland/drug effects
9.
Alcohol ; 14(2): 107-10, 1997.
Article in English | MEDLINE | ID: mdl-9085709

ABSTRACT

The objective of this study was to determine if chronic ethanol consumption could modify cell populations in the Peyer's patches (PP), which could favor pathogenic or opportunistic infections in mice, as seen in chronic alcohol addicts. Young C57BL/6 mice receiving the Lieber-DeCarli diet (36% of calories as ethanol) for 5 weeks presented a significant decrease in the total number of cells in the PP. Mature FVB mice receiving the Lieber-DeCarli diet for 19 weeks presented a highly significant decrease in the total number of cells and in the absolute number of T and B cells in the PP. Young C57BL/6 mice receiving the 100% NRC (30% ethanol) or the 60% NRC (30% ethanol) diets for 7 weeks presented alterations in the T and B cell phenotype comparable with the alterations observed in mice receiving the Lieber-DeCarli diet for 19 weeks. As less alcohol for a shorter time caused similar changes to those seen with a highly micronutrient enriched diet with more alcohol for a longer consumption period, micronutrient supplementation may overcome some immune damage found in animal models of alcoholism. Our data indicated that ethanol administration altered the mucosal immune system at the level of the PP, the site for antigen presentation and induction of a mucosal immune response.


Subject(s)
Ethanol/administration & dosage , Lymphocyte Count , Peyer's Patches/cytology , Phenotype , Alcoholism/immunology , Animals , B-Lymphocytes , Diet , Energy Intake , Female , Male , Mice , Mice, Inbred C57BL , T-Lymphocytes
10.
Int J Immunopharmacol ; 18(4): 251-8, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8894804

ABSTRACT

The objective was to investigate if the presence of the v-Ha-ras oncogene could induce immune changes different to the ones observed in normal mice. Therefore, we decided to use Oncomice, the transgenic mice with an activated v-Ha-ras oncogene under the control of the mouse mammary tumor virus-promoter, and their normal inbred counterparts, FVB mice. Both strains of mice were fed the Lieber-DeCarli liquid diet with ethanol or the isocaloric control diet and were injected daily with cocaine or saline. The percentage and absolute number of T and B lymphocytes in the spleen and thymus were determined. The in vitro production of TNF-alpha (tumor necrosis factor-alpha), IL-2 (interleukin-2) and IFN-gamma (interferon-gamma) by spleen cells, and the levels of serum sIL-2R (soluble IL-2 receptor) were also measured. Oncomice fed the Lieber-DeCarli ethanol diet or receiving either saline or cocaine injections presented a higher tumor incidence than Oncomice receiving the control diet. A reduced total number of thymocytes as well as absolute number of cells in all the subsets was found in Oncomice. Moreover, a decreased percentage of CD8+ cells was also observed in Oncomouse spleens. These features were even more marked in ethanol-treated Oncomice. Higher serum sIL-2R levels were observed in Oncomice, especially in mice treated with ethanol or cocaine. The results suggest that the oncogene product, P21ras, plays an important role in dysregulating the immune system and hence in favoring tumorigenesis.


Subject(s)
Cocaine/toxicity , Ethanol/toxicity , Genes, ras/genetics , Immune System/drug effects , Animals , Body Weight/drug effects , Cells, Cultured , Female , Interferon-gamma/biosynthesis , Interferon-gamma/drug effects , Interleukin-2/biosynthesis , Mice , Mice, Transgenic , Receptors, Interleukin-2/biosynthesis , Receptors, Interleukin-2/blood , Receptors, Interleukin-2/drug effects , Spleen/cytology , Spleen/drug effects , Spleen/metabolism , Thymus Gland/drug effects , Transgenes/genetics , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/drug effects
11.
Oncogene ; 9(12): 3627-33, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7970723

ABSTRACT

Activated ras genes are known to alter control of cell proliferation. This is consistent with the fact that ras proteins are a key component of the biochemical pathway triggered by ligand-bound cell surface receptors that are tyrosine kinases. Although an important part of the ras signaling pathway has been recently uncovered, the molecular target(s) that mediates the effects of ras on cell cycle control remains unknown. Cyclins and cyclin-dependent kinases are key molecules in the control of cell cycle. Cyclin D1, in particular, is a critical target for proliferative signals in G1 and it has been shown that ectopic overexpression of this cyclin can significantly alter cell cycle regulation. Here we report that activated ras induces significant overexpression of cyclin D1 in epithelial cells derived from normal rat intestine and mouse mammary gland. A definitive causal role for activated ras in this overexpression is demonstrated by using intestinal cells transfected with an inducible ras expression vector. Treatment of the ras-transformed intestinal clones with anti-sense cyclin D1 oligonucleotides reduces their rate of cell proliferation indicating that the increment in cyclin D1 expression induced by activated ras is instrumental in the higher rate of cell proliferation conferred by the ras oncogene to the IEC cells. Based on these results we propose that, at least in certain cell types, cyclin D1 can be one of the mediators of the transforming action of activated ras.


Subject(s)
Cyclins/genetics , Genes, ras , Oncogene Proteins/genetics , Animals , Base Sequence , Cell Cycle/genetics , Cell Line , Cyclin D1 , DNA, Complementary , Intestines/cytology , Molecular Sequence Data , Rats
12.
Int J Immunopharmacol ; 15(8): 899-907, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8253540

ABSTRACT

Severe infections in intravenous drug abusers could be the consequence of morphine-induced damage on the immune system. To evaluate the long-term effect of in vivo morphine administration on the immune system we developed an experimental model where we studied the combined effects of morphine treatment and protein malnutrition. We treated protein-undernourished mice daily for 11 weeks with increasing doses of morphine. Morphine treatment produced a decrease in body weight and spleen cell number. The changes observed were partially independent of the nutritional status of the host. Saline-injected mice showed a decrease in the percentage of Thy 1+ cells in the spleen. Morphine treatment induced a decrease in the total number of cells and therefore in the absolute number of T-(Thy 1, CD4, CD8), B- and Mac 1+ (macrophages) cells in protein-undernourished mice. Saline-injected mice showed a decrease in the percentage of Thy 1+ cells and an increase in the percentage of B- and Ia(+)-cells in the spleen. We conclude that morphine altered the immune system by down-regulating splenocyte proliferation. We also studied the effects of i.p. administered morphine on expression of thymocyte phenotype in well-nourished and protein-undernourished mice. In well-nourished mice, morphine treatment reduced the number of Thy 1+, CD4+ and CD8+ cells per thymus to 30% of that found in untreated mice and to 40% of the cells in those saline-treated controls.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Morphine/administration & dosage , Morphine/toxicity , Protein Deficiency/immunology , T-Lymphocytes/drug effects , Animals , Enzyme-Linked Immunosorbent Assay , Female , Interferon-gamma/biosynthesis , Macrophages/drug effects , Mice , Mice, Inbred C57BL , Receptors, Interleukin-2/metabolism , Spleen/cytology , T-Lymphocytes, Helper-Inducer/drug effects , T-Lymphocytes, Regulatory/drug effects , Thymus Gland/cytology , Tumor Necrosis Factor-alpha/biosynthesis
13.
Int J Immunopharmacol ; 15(8): 909-18, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8253541

ABSTRACT

Intravenous heroin abusers suffer a great variety of infections, including AIDS (acquired immune deficiency syndrome). We developed an experimental mouse model to evaluate the long-term effect of in vivo morphine administration during retrovirus-induced immune dysfunction. Mice were treated daily for 11 weeks with increasing doses of morphine. Morphine treatment produced a decrease in body weight and spleen cell number. Murine retrovirus infection provoked an increase in body weight due to enlargement of lymphoid organs, and an increase in the percentage and absolute number of CD4+ and Mac 1+ cells. Interestingly, retrovirus-infected mice that were also morphine-treated did not show the increase in the relative proportion of Mac 1+ cells. Moreover, under the experimental conditions of protein-malnutrition and morphine treatment potentiation of immune dysfunction by murine retrovirus infection was investigated. Retrovirus infection-induced splenocyte proliferation was partially regulated by morphine treatment. Splenocytes from retrovirus-infected mice presented a higher percentage of IL-2R+ cells and, lower levels of sIL-2R in splenocyte supernatants. Mitogen-stimulated splenocytes had a lower production of interferon-gamma as well as an increase in the secretion of tumor necrosis factor-alpha. Thus morphine altered the immune system by down-regulating splenocyte proliferation, because retrovirus infection-induced splenocyte proliferation was partially regulated by morphine treatment. We also evaluated the effects of joint murine retrovirus infection and protein undernutrition on the thymus cell subsets. Retrovirus infection was associated with a decrease in the absolute number of Thy 1+, CD4+ and CD8+ cells per thymus with the CD8+ cell subset being the most affected. Moreover, retrovirus-infected mice presented a dramatic decrease in the percentage of double-positive (CD4+ CD8+) cells in the thymus as well as changes in its immunoarchitecture. While protein undernutrition alone did not produce further differences between infected versus non-infected, protein-undernourished, morphine treatment induced a greater decrease in thymocyte number than that seen in retrovirus- or morphine-treated animals alone.


Subject(s)
Leukemia Virus, Murine , Morphine/toxicity , Murine Acquired Immunodeficiency Syndrome/immunology , Animals , Cells, Cultured , Enzyme-Linked Immunosorbent Assay , Female , Interferon-gamma/biosynthesis , Lipopolysaccharides , Macrophages/drug effects , Mice , Mice, Inbred C57BL , Morphine/administration & dosage , Receptors, Interleukin-2/metabolism , Spleen/cytology , T-Lymphocytes/drug effects , Thymus Gland/cytology , Tumor Necrosis Factor-alpha/biosynthesis
14.
Cancer Lett ; 74(3): 147-50, 1993 Nov 01.
Article in English | MEDLINE | ID: mdl-7513605

ABSTRACT

Mice containing the activated v-Ha-ras oncogene driven by the mouse mammary tumor virus promoter/enhancer produced less tumor necrosis factor (TNF) than genetically identical animals without it. Inbred Oncomice containing the v-Ha-ras oncogene and inbred FVB mice without it were grown for 6 months. Splenocytes were isolated and stimulated in vitro to produce tumor necrosis factor (TNF) and gamma-interferon (IFN). TNF production by cells from Oncomice was significantly decreased compared to cells from FBV mice. There was a tendency for decrease, but no significant difference was seen on IFN release. These observations suggest that the oncogene may play a role in the immune system.


Subject(s)
Genes, ras , Spleen/metabolism , Tumor Necrosis Factor-alpha/biosynthesis , Animals , Cells, Cultured , Female , Interferons/biosynthesis , Mice , Mice, Inbred Strains , Spleen/cytology
15.
Alcohol Clin Exp Res ; 17(3): 623-30, 1993 Jun.
Article in English | MEDLINE | ID: mdl-8333593

ABSTRACT

Chronic ethanol (ETOH) ingestion adversely affects the immunocompetence of alcohol abusers. ETOH directly impairs host defense mechanisms and indirectly modulates immunocompetence by interfering with the nutritional status of the alcoholic. It is not clear from the current literature, however, to what extent ETOH, nutritional status, or the combination of the two factors modulates immune mechanisms in chronic alcoholics. To date, most animal studies investigating the immunotoxicity of ETOH have neglected the dietary factors, which may have masked additional immunotoxic effects of ETOH. To examine these dietary factors, we fed mice three liquid ETOH diets with different dietary sufficiencies for 7 weeks and investigated various immune responses. Spleen cell number and secretions of immunoreactive interleukin-2 and tumor necrosis factor were totally independent of the diet, being affected only by ETOH. Body, spleen, and thymus weights, interferon-gamma secretion, and natural killer cell and phagocytic activities were modulated by ETOH as well as by diet. Natural killer cell and phagocytic activities were also directly affected by the nutritional quality of the diet. These results suggest that animal diets used in experimental studies of ETOH-induced immunomodulation must be planned and controlled carefully in order to single out the direct effects that ETOH has on the host defense system.


Subject(s)
Alcoholism/immunology , Deficiency Diseases/immunology , Feeding Behavior/physiology , Immunocompetence/immunology , Animals , B-Lymphocytes/immunology , Body Weight/physiology , Cytokines/metabolism , Energy Metabolism/physiology , Ethanol/pharmacokinetics , Female , Immune Tolerance/immunology , Killer Cells, Natural/immunology , Leukocyte Count , Mice , Mice, Inbred C57BL , Phagocytosis/immunology
16.
Thymus ; 20(3): 171-81, 1992 Nov.
Article in English | MEDLINE | ID: mdl-1334287

ABSTRACT

Retrovirus infection, cocaine administration, and nutritional deficiencies are known to individually produce impairment of the immune system. Therefore, we developed a murine model to study the effect of daily cocaine administration, protein malnutrition, and retrovirus infection causing murine AIDS on the lymphoid cell populations of the thymus. C57BL/6 female mice fed a diet containing 4% protein were studied following chronic cocaine administration and LP-BM5 murine leukemia virus (MuLV) infection. Cocaine administration reduced body and thymus weight. Cocaine partially prevented thymus enlargement due to lymphoid cell proliferation induced by murine retrovirus infection. Cocaine treatment affected dramatically the thymus of protein-malnourished mice where the absolute number of Thy 1.2+, CD4+ and CD8+ cells represented only 10% of the control values. Daily saline injection also induced a significant decrease in the number of Thy 1.2+, CD4+ and CD8+ cells per thymus. These results suggest that the thymus glands of mice fed a low protein diet were susceptible to stress. Retrovirus infection provoked a decrease in the percentage and absolute number of Thy 1.2+, CD4+ and CD8+ cells in the thymus. This effect was potentiated by cocaine treatment. Therefore, cocaine was able to potentiate the impairment of the immune system caused by MuLV infection. We consider that cocaine could alter the immune system by altering the expression of T cell differentiation markers after direct interaction with thymocytes or through the neuroendocrine-thymus axis. Moreover, this effect was more dramatic and severe during protein malnutrition.


Subject(s)
Cocaine/pharmacology , Immunologic Deficiency Syndromes/etiology , Murine Acquired Immunodeficiency Syndrome/immunology , Protein Deficiency/immunology , T-Lymphocyte Subsets/drug effects , Thymus Gland/pathology , Animals , Biomarkers , Cocaine/toxicity , Disease Models, Animal , Female , Immunocompromised Host , Immunologic Deficiency Syndromes/chemically induced , Immunologic Deficiency Syndromes/microbiology , Immunologic Deficiency Syndromes/pathology , Leukemia Virus, Murine , Leukocyte Count , Mice , Mice, Inbred C57BL , Murine Acquired Immunodeficiency Syndrome/complications , Murine Acquired Immunodeficiency Syndrome/pathology , Organ Size/drug effects , Protein Deficiency/complications , Protein Deficiency/pathology , Thymus Gland/drug effects , Thymus Gland/microbiology
17.
Clin Immunol Immunopathol ; 65(1): 45-52, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1395123

ABSTRACT

LP-BM5 murine leukemia virus (MuLV) infection and cocaine administration are known to impair the murine immune system. We have developed a murine model to study the effect of daily cocaine administration and retrovirus infection on the lymphoid cell populations of the thymus. C57BL/6 female mice were studied following chronic cocaine administration for 11 weeks with simultaneous LP-BM5 MuLV infection. Cocaine administration reduced body and thymus weight, significantly reduced the number of CD8+ cells in the thymus, and partially prevented thymus enlargement due to lymphoid cell proliferation induced by LP-BM5 MuLV infection. Retrovirus infection was associated with a decrease in the percentage and absolute number of Thy 1.2+, CD4+, and CD8+ cells in the thymus, an effect potentiated by cocaine administration. Therefore cocaine impairs thymic function by altering the number of cells expressing T cell differentiation markers in MAIDS.


Subject(s)
Cocaine/administration & dosage , Murine Acquired Immunodeficiency Syndrome/blood , T-Lymphocyte Subsets/drug effects , Animals , CD4-CD8 Ratio , Cell Count , Female , Interferon-gamma/metabolism , Mice , Mice, Inbred C57BL , Organ Size , Receptors, Interleukin-2/metabolism , Spleen/cytology , T-Lymphocyte Subsets/microbiology , Thymus Gland/cytology , Thymus Gland/metabolism , Thymus Gland/physiology , Time Factors
18.
Immunol Lett ; 33(2): 123-6, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1446916

ABSTRACT

Previously, we demonstrated that production of gamma-interferon (gamma-IFN) by the mouse splenocytes isolated at night was higher than from those isolated in the morning. In this paper we show that melatonin increased gamma-IFN production by murine splenocytes. Moreover, this stimulating effect was significantly higher (10 times) in the cells isolated at night than in those isolated in the morning (2 times).


Subject(s)
Circadian Rhythm , Interferon-gamma/metabolism , Melatonin/pharmacology , Spleen/drug effects , Animals , Cells, Cultured , Concanavalin A , Enzyme-Linked Immunosorbent Assay , Female , Mice , Mice, Inbred C57BL , Receptors, Interleukin-2/metabolism , Spleen/cytology
19.
Int J Rad Appl Instrum B ; 19(5): 589-96, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1399688

ABSTRACT

The expression of cell surface antigens of the spontaneous transplantable M3-murine tumour was studied by means of the monoclonal antibody (MAb) B2C114 which recognizes the human blood group-A carbohydrate antigen. Following radioiodination the MAb retained their immunoreactivity and demonstrated a significantly higher in vitro binding with isolated M3-tumour cells as compared with a control antibody. B2C114 revealed 10(6) antigenic sites per cell, with a constant affinity of 5.1 x 10(9)/M. Biodistribution studies showed that B2C114 discriminated between malignant tumour and mouse normal tissues. Radioimmunodetection of Balb/c mice bearing s.c. M3-tumour showed that tumour was specifically defined without subtraction 1 day after injection of the radiolabelled antibody.


Subject(s)
Adenocarcinoma/diagnostic imaging , Antibodies, Monoclonal/metabolism , Mammary Neoplasms, Experimental/diagnostic imaging , ABO Blood-Group System/immunology , Adenocarcinoma/metabolism , Animals , Antibodies, Monoclonal/isolation & purification , Female , Injections, Intraperitoneal , Iodine Radioisotopes , Mammary Neoplasms, Experimental/metabolism , Mice , Mice, Inbred BALB C , Radionuclide Imaging , Tissue Distribution , Tumor Cells, Cultured/metabolism
20.
Reg Immunol ; 4(3): 162-7, 1992.
Article in English | MEDLINE | ID: mdl-1338892

ABSTRACT

LP-BM5 murine leukemia virus (MuLV) infection induces an immunodeficient state in susceptible strains of mice. It has been previously characterized at the level of spleen and peripheral lymph nodes. We recently demonstrated that LP-BM5 MuLV-infected mice lost intestinal host resistance to common opportunistic pathogens. In this article we investigated how murine retroviral infection alters the differentiation of IgA B cell precursors in Peyer's patches (PP), mesenteric lymph nodes (MLN), and the intestinal lamina propria (ILP). After 4 months of LP-BM5 MuLV infection, there was a significant decrease in the absolute numbers of Thy1+, CD4+, and CD8+ cells in PP with a concomitant decrease in the percentage and in the absolute numbers of surface IgA+--(sIgA+) and surface IgM+--bearing (sIgM+) cells. Infection also produced an enlarged MLN with a six-fold increase in cell numbers and a decrease in the relative percentage of sIgA+, cytoplasmic IgA+, and cytoplasmic IgM+ cells. However, murine retrovirus infection caused no significant changes in the percentages of Thyl+, CD4+, CD8+, and CD5+ cells in the MLN. After 4 months of murine retrovirus infection cIgA+ cells from MLN were not able to populate the intestinal lamina propria as the number of IgA plasma cells was significantly decreased. Moreover, there was a concomitant decrease in the number of CD4+ cells per field in the ILP. These results suggest that murine retrovirus infection favors the expansion of IgA B cell precursors at the level of MLN, while simultaneously interfering with the terminal differentiation step and thus preventing IgA plasma cell precursors from seeding the ILP.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Leukemia Virus, Murine , Lymphocyte Subsets/immunology , Murine Acquired Immunodeficiency Syndrome/immunology , Animals , B-Lymphocyte Subsets/immunology , B-Lymphocyte Subsets/pathology , Cell Count , Cell Differentiation , Female , Hematopoietic Stem Cells/immunology , Hematopoietic Stem Cells/pathology , Immune Tolerance , Immunoglobulin A/metabolism , Intestine, Small/immunology , Intestine, Small/pathology , Lymph Nodes/immunology , Lymph Nodes/pathology , Lymphocyte Subsets/pathology , Mice , Mice, Inbred C57BL , Murine Acquired Immunodeficiency Syndrome/pathology , Peyer's Patches/immunology , Peyer's Patches/pathology , Plasma Cells/immunology , Plasma Cells/pathology , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...